Business Context and Reporting Period
Company: Molina Healthcare, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 11, 2004
Reporting Period: The filing announces financial results for the quarter and full year ended December 31, 2003, and provides guidance for the full calendar year 2004.
Key Financial Metrics
The filing text does not provide specific historical financial results (revenue, profit, cash flow, or margins) for the period ended December 31, 2003, stating only that the full text of the press release containing these figures is included as Exhibit 99.1. The following metrics are provided as guidance for 2004:
- Net Income (Q1 2004): $10.1 million to $10.4 million.
- Net Income (Full Year 2004): $47.5 million to $50.2 million.
- Earnings Per Diluted Share (Q1 2004): $0.39 to $0.40.
- Earnings Per Diluted Share (Full Year 2004): $1.83 to $1.93.
- Premium Revenue (Full Year 2004): $922.7 million to $943.5 million.
- Medical Care Ratio (Full Year 2004): 83.0% to 83.2% of premium and other operating revenue.
- Administrative Costs (Full Year 2004): 8.0% to 8.3% of total revenue.
- Enrollment Growth (Full Year 2004): 6% to 9% (excluding acquisitions).
Material Changes and Unusual Items
The filing does not detail specific material changes to historical performance versus prior periods. However, it notes the following assumptions and unusual items affecting the 2004 guidance:
- One-Time Gain: Estimates include a favorable one-time effect of $1.1 million (pretax) from the anticipated termination of a split dollar life insurance arrangement with a related party.
- Tax Rate Assumption: Guidance assumes an effective tax rate of 37.5%, excluding any favorable state tax credits from prior periods that might be received in 2004.
- Share Count: Estimates assume an average of 26.0 million diluted shares outstanding in 2004.
Guidance and Outlook
Management reconfirmed guidance previously issued on November 6, 2003, regarding enrollment growth and administrative costs. The outlook for 2004 anticipates steady growth in premium revenue and enrollment, with controlled medical care ratios and administrative expenses. The company held a conference call on February 11, 2004, to discuss these results and guidance.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the actual historical financial results for the quarter and year ended December 31, 2003, which are not detailed in the 8-K text.
- Verify the realization of the $1.1 million one-time gain from the split dollar life insurance termination.
- Monitor actual state tax credit receipts in 2004, as the guidance excludes potential favorable impacts.
- Track enrollment growth to ensure it remains within the 6% to 9% range excluding acquisitions.
- Confirm the average diluted share count remains near 26.0 million to validate EPS estimates.